228 related articles for article (PubMed ID: 22592652)
1. Central nervous system involvement of primary cutaneous diffuse large B cell lymphoma-leg type diagnosed according to the WHO 2008 classification.
Aoki K; Arima H; Tabata S; Matsushita A; Ishikawa T; Takahashi T
Ann Hematol; 2012 Dec; 91(12):1975-6. PubMed ID: 22592652
[No Abstract] [Full Text] [Related]
2. Primary cutaneous diffuse large B-cell lymphoma (leg type) after renal allograft.
Zhao J; Han B; Shen T; Zhao Y; Wang T; Liu Y; Fang K
Eur J Haematol; 2008 Aug; 81(2):163. PubMed ID: 18363873
[No Abstract] [Full Text] [Related]
3. Primary cutaneous diffuse large B cell lymphoma, leg type.
Dongre A; Kar S; Gondse S; Gangane N; Mehra BK
Indian J Dermatol Venereol Leprol; 2011; 77(2):212-4. PubMed ID: 21393962
[No Abstract] [Full Text] [Related]
4. Secondary central nervous system (CNS) involvement in patients with diffuse large B-cell lymphoma: a therapeutic dilemma.
Kim SJ; Oh SY; Kim JS; Kim H; Lee GW; Won JH; Shin HJ; Yang DH; Choi CW; Park J; Kim WS; Suh C
Ann Hematol; 2011 May; 90(5):539-46. PubMed ID: 20960190
[TBL] [Abstract][Full Text] [Related]
5. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
[TBL] [Abstract][Full Text] [Related]
6. Primary cutaneous diffuse large B-cell lymphoma, leg-type, treated with a modified R-CHOP immunochemotherapy - diagnostic and therapeutic challenges.
Wobser M; Kneitz H; Bröcker EB; Becker JC
J Dtsch Dermatol Ges; 2011 Mar; 9(3):204-11. PubMed ID: 21122066
[TBL] [Abstract][Full Text] [Related]
7. Primary cutaneous large B-cell lymphoma, leg type, successfully treated with rituximab plus chemotherapy.
Posada García C; Florez A; Pardavila R; Garcia-Cruz A; Amador L; Alvarez M; Alberte LM; Cruces MJ
Eur J Dermatol; 2009; 19(4):394-5. PubMed ID: 19467966
[No Abstract] [Full Text] [Related]
8. Durable remission of intravascular lymphoma with central nervous system involvement following chemotherapy and rituximab.
Go A; Venugopal P; Loew J; Djordjevic D
Clin Adv Hematol Oncol; 2006 Jun; 4(6):439-41. PubMed ID: 16981666
[No Abstract] [Full Text] [Related]
9. Isolated limb perfusion with melphalan for the treatment of intractable primary cutaneous diffuse large B-cell lymphoma leg type.
Kobold S; Killic N; Lütkens T; Bokemeyer C; Fiedler W
Acta Haematol; 2010; 123(3):179-81. PubMed ID: 20224270
[No Abstract] [Full Text] [Related]
10. Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.
Tomita N; Yokoyama M; Yamamoto W; Watanabe R; Shimazu Y; Masaki Y; Tsunoda S; Hashimoto C; Murayama K; Yano T; Okamoto R; Kikuchi A; Tamura K; Sato K; Sunami K; Shibayama H; Takimoto R; Ohshima R; Hatta Y; Moriuchi Y; Kinoshita T; Yamamoto M; Numata A; Ishigatsubo Y; Takeuchi K
Cancer Sci; 2012 Feb; 103(2):245-51. PubMed ID: 22044593
[TBL] [Abstract][Full Text] [Related]
11. [Primary cutaneous diffuse large B-cell lymphoma, leg type: report of a case].
Lu XY; Lu C; Yin YL; Yu B
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):416-7. PubMed ID: 21055163
[No Abstract] [Full Text] [Related]
12. Central nervous system involvement in diffuse large B-cell lymphoma.
Yamamoto W; Tomita N; Watanabe R; Hattori Y; Nakajima Y; Hyo R; Hashimoto C; Motomura S; Ishigatsubo Y
Eur J Haematol; 2010 Jul; 85(1):6-10. PubMed ID: 20236301
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
[TBL] [Abstract][Full Text] [Related]
14. Primary central nervous system lymphoma: an unusual presentation.
Heckmann JM; O'Ryan S; Candy S
S Afr Med J; 2008 Nov; 98(11):851-2. PubMed ID: 19177889
[No Abstract] [Full Text] [Related]
15. [Treatment strategy for central nervous system involvement in intravascular large B-cell lymphoma].
Shimada K
Brain Nerve; 2011 May; 63(5):467-72. PubMed ID: 21515926
[TBL] [Abstract][Full Text] [Related]
16. Central nervous system (CNS) relapse in diffuse large B cell lymphoma (DLBCL): pre- and post-rituximab.
Tai WM; Chung J; Tang PL; Koo YX; Hou X; Tay KW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Jul; 90(7):809-18. PubMed ID: 21229246
[TBL] [Abstract][Full Text] [Related]
17. Relapse of primary central nervous system lymphoma 13 years after high-dose methotrexate-based polychemotherapy.
Steinbeck JA; Stuplich M; Blasius E; Pels H; Glas M; Schlegel U; Herrlinger U
J Clin Neurosci; 2011 Nov; 18(11):1554-5. PubMed ID: 21868233
[TBL] [Abstract][Full Text] [Related]
18. Intravascular large B-cell lymphoma of the skin: typical clinical manifestations and a favourable response to rituximab-containing therapy.
Feldmann R; Schierl M; Sittenthaler M; Jahn R; Wogritsch C; Cerroni L; Steiner A; Breier F
Dermatology; 2009; 219(4):344-6. PubMed ID: 19590171
[TBL] [Abstract][Full Text] [Related]
19. CNS prophylaxis in diffuse large B-cell lymphoma: if, when, how and for whom?
Siegal T; Goldschmidt N
Blood Rev; 2012 May; 26(3):97-106. PubMed ID: 22244544
[TBL] [Abstract][Full Text] [Related]
20. Perineural CNS invasion in primary cutaneous follicular center lymphoma.
Buda-Okreglak EM; Walden MJ; Brissette MD
J Clin Oncol; 2007 Oct; 25(29):4684-6. PubMed ID: 17925565
[No Abstract] [Full Text] [Related]
[Next] [New Search]
